Complement C3 variant and the risk of age-related macular degeneration.

BACKGROUND Age-related macular degeneration is the most common cause of blindness in Western populations. Susceptibility is influenced by age and by genetic and environmental factors. Complement activation is implicated in the pathogenesis. METHODS We tested for an association between age-related macular degeneration and 13 single-nucleotide polymorphisms (SNPs) spanning the complement genes C3 and C5 in case subjects and control subjects from the southeastern region of England. All subjects were examined by an ophthalmologist and had independent grading of fundus photographs to confirm their disease status. To test for replication of the most significant findings, we genotyped a set of Scottish cases and controls. RESULTS The common functional polymorphism rs2230199 (Arg80Gly) in the C3 gene, corresponding to the electrophoretic variants C3S (slow) and C3F (fast), was strongly associated with age-related macular degeneration in both the English group (603 cases and 350 controls, P=5.9x10(-5)) and the Scottish group (244 cases and 351 controls, P=5.0x10(-5)). The odds ratio for age-related macular degeneration in C3 S/F heterozygotes as compared with S/S homozygotes was 1.7 (95% confidence interval [CI], 1.3 to 2.1); for F/F homozygotes, the odds ratio was 2.6 (95% CI, 1.6 to 4.1). The estimated population attributable risk for C3F was 22%. CONCLUSIONS Complement C3 is important in the pathogenesis of age-related macular degeneration. This finding further underscores the influence of the complement pathway in the pathogenesis of this disease.

[1]  Johanna M Seddon,et al.  The genetics of age-related macular degeneration: a review of progress to date. , 2006, Survey of ophthalmology.

[2]  P. Mathieson,et al.  Molecular analysis of C3 allotypes in patients with nephritic factor , 1993, Clinical and experimental immunology.

[3]  P T de Jong,et al.  An international classification and grading system for age-related maculopathy and age-related macular degeneration , 1995 .

[4]  N. Behrendt,et al.  A novel polymorphism of human complement component C3 detected by means of a monoclonal antibody , 2004, Immunogenetics.

[5]  P. Mathieson,et al.  Molecular analysis of C3 allotypes in patients with systemic vasculitis. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  N. Orr,et al.  A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration , 2006, Nature Genetics.

[7]  D. Patel,et al.  Ocular complications in acquired partial lipodystrophy , 2006, Postgraduate Medical Journal.

[8]  T. Welch,et al.  Functional consequences of the genetic polymorphism of the third component of complement. , 1990, The Journal of pediatrics.

[9]  Gudmundur A. Thorisson,et al.  The International HapMap Project Web site. , 2005, Genome research.

[10]  D. Clayton,et al.  Complement Factor H Variant Y 402 H Is a Major Risk Determinant for Geographic Atrophy and Choroidal Neovascularization in Smokers and Nonsmokers , 2006 .

[11]  J. Winkelstein,et al.  Genetically determined variation in the complement system: relationship to disease. , 1984, The Journal of pediatrics.

[12]  Yun Li,et al.  CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration , 2006, Nature Genetics.

[13]  P.T.V.M. de Jong,et al.  Mechanisms of disease: Age-related macular degeneration , 2006 .

[14]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[16]  John D Lambris,et al.  Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. , 2005, Journal of the American Society of Nephrology : JASN.

[17]  C. Barnstable,et al.  HTRA1 Promoter Polymorphism in Wet Age-Related Macular Degeneration , 2006, Science.

[18]  M. Rambausek,et al.  Genetic polymorphism of C3 and Bf in IgA nephropathy. , 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[19]  Ian J Deary,et al.  The impact of childhood intelligence on later life: following up the Scottish mental surveys of 1932 and 1947. , 2004, Journal of personality and social psychology.

[20]  O. Smithies,et al.  Genetic polymorphism of C'3(beta1C-globulin) in human serum. , 1968, Science.

[21]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[22]  D. Clayton,et al.  Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. , 2006, Investigative ophthalmology & visual science.

[23]  H. Arvilommi.  Capacity of complement C3 phenotypes to bind on to mononuclear cells in man , 1974, Nature.

[24]  D. Weeks,et al.  Susceptibility genes for age-related maculopathy on chromosome 10q26. , 2005, American journal of human genetics.

[25]  N. Camp,et al.  A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration , 2006, Science.

[26]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[27]  M. Walport,et al.  Comparison of the binding of C3S and C3F to complement receptors types 1, 2, and 3. , 1995, Journal of immunology.

[28]  M. Walport,et al.  Molecular basis of polymorphisms of human complement component C3 , 1990, The Journal of experimental medicine.

[29]  M. Walport,et al.  Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H , 2002, Nature Genetics.

[30]  H. Kaplan,et al.  Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Johanna M Seddon,et al.  Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.

[32]  O. Smithies,et al.  Genetic Polymorphism of C'3(β1c-Globuiin) in Human Serum , 1968, Science.

[33]  S. Russell,et al.  Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  G. Hageman,et al.  Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis , 2001, Eye.

[35]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[36]  D. Colville,et al.  Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease"). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  J. H. Jansen,et al.  Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. , 1995, The Journal of clinical investigation.

[38]  C. Barnstable,et al.  Supporting Online Material for HTRA 1 Promoter Polymorphism in Wet Age-Related Macular Degeneration , 2006 .

[39]  R. Vaughan,et al.  Influence of donor C3 allotype on late renal-transplantation outcome. , 2006, The New England journal of medicine.

[40]  A. Goldman,et al.  Structure of complement factor H carboxyl‐terminus reveals molecular basis of atypical haemolytic uremic syndrome , 2006, The EMBO journal.

[41]  Piet Gros,et al.  Structure of C3b reveals conformational changes that underlie complement activity , 2006, Nature.

[42]  J L McRae,et al.  Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease) , 2005, Journal of Medical Genetics.